Orthotopic & Metastatic Xenograft Studies in the SRG Rat

Time: 11:45 am
day: Day Two

Details:

The SRG rat is an ideal highly immunodeficient xenograft host which provides advantages for preclinical in vivo drug efficacy studies including higher tumor takerates, serial tumor biopsies, and combination metabolism/safety studies. Hera
will present data on novel applications of the SRG rat including metastatic and orthotopic tumor models

Speakers: